Citadel Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.1M Sell
872,975
-778,115
-47% -$20.6M ﹤0.01% 879
2025
Q1
$39.9M Buy
1,651,090
+166,011
+11% +$4.01M 0.01% 571
2024
Q4
$59.8M Buy
1,485,079
+12,403
+0.8% +$499K 0.01% 466
2024
Q3
$93.2M Buy
1,472,676
+1,006,198
+216% +$63.7M 0.02% 258
2024
Q2
$24.7M Sell
466,478
-435,271
-48% -$23.1M 0.01% 776
2024
Q1
$73.9M Buy
901,749
+830,182
+1,160% +$68.1M 0.01% 353
2023
Q4
$1.33M Buy
+71,567
New +$1.33M ﹤0.01% 2760
2023
Q3
Sell
-89,717
Closed -$1.45M 6563
2023
Q2
$1.45M Sell
89,717
-59,475
-40% -$964K ﹤0.01% 2681
2023
Q1
$2.48M Buy
149,192
+125,236
+523% +$2.09M ﹤0.01% 2353
2022
Q4
$225K Sell
23,956
-28,291
-54% -$266K ﹤0.01% 4591
2022
Q3
$143K Sell
52,247
-67,603
-56% -$185K ﹤0.01% 4984
2022
Q2
$347K Sell
119,850
-491,795
-80% -$1.42M ﹤0.01% 4494
2022
Q1
$1.84M Buy
611,645
+348,646
+133% +$1.05M ﹤0.01% 3102
2021
Q4
$1.21M Buy
262,999
+138,954
+112% +$639K ﹤0.01% 3597
2021
Q3
$779K Sell
124,045
-59,285
-32% -$372K ﹤0.01% 4041
2021
Q2
$1.1M Buy
183,330
+111,631
+156% +$669K ﹤0.01% 3904
2021
Q1
$454K Sell
71,699
-192,071
-73% -$1.22M ﹤0.01% 4652
2020
Q4
$1.49M Buy
263,770
+132,536
+101% +$746K ﹤0.01% 2875
2020
Q3
$763K Buy
131,234
+40,426
+45% +$235K ﹤0.01% 3148
2020
Q2
$655K Buy
90,808
+69,600
+328% +$502K ﹤0.01% 3224
2020
Q1
$99K Buy
+21,208
New +$99K ﹤0.01% 4364
2019
Q4
Hold
0
5167
2019
Q3
Sell
-37,111
Closed -$308K 5170
2019
Q2
$308K Sell
37,111
-1,036,463
-97% -$8.6M ﹤0.01% 3854
2019
Q1
$10.7M Buy
1,073,574
+76,029
+8% +$756K 0.01% 1081
2018
Q4
$7.63M Buy
997,545
+47,844
+5% +$366K ﹤0.01% 1162
2018
Q3
$16.5M Buy
949,701
+506,430
+114% +$8.82M 0.01% 843
2018
Q2
$4.21M Buy
443,271
+428,296
+2,860% +$4.06M ﹤0.01% 1540
2018
Q1
$65K Buy
+14,975
New +$65K ﹤0.01% 3705
2017
Q4
Sell
-56,461
Closed -$108K 4306
2017
Q3
$108K Buy
+56,461
New +$108K ﹤0.01% 3339
2016
Q3
Sell
-16,624
Closed -$21K 4122
2016
Q2
$21K Buy
16,624
+3,580
+27% +$4.52K ﹤0.01% 3179
2016
Q1
$19K Buy
+13,044
New +$19K ﹤0.01% 3156